Vivek Vasudeo

Rajiv Gandhi Cancer Institute and Research Centre

Papers

4

Total Citations

22

H-Index

3

About

Dr. Vivek Vasudeo is a pioneering uro-oncologist whose work centers on advancing minimally invasive surgical techniques for complex genitourinary cancers. His primary research focuses on the application of robotic surgery in testicular, upper-tract urothelial, and penile cancers. Dr. Vasudeo’s major contributions include demonstrating the safety and efficacy of robot-assisted retroperitoneal lymph node dissection (RA-RPLND) for post-chemotherapy residual masses in testicular cancer, with his landmark 2022 study—the largest single-center experience of its kind—garnering 11 citations. He has also provided crucial comparative evidence showing that robot-assisted radical nephroureterectomy offers superior outcomes over laparoscopic approaches for upper-tract urothelial carcinoma. Notably, Dr. Vasudeo led the first Indian multicenter experience of robot-assisted video endoscopic inguinal lymph node dissection for penile cancer, a study that has already received 4 citations. His work with the indigenous SSI Mantra™ surgical robotic system further underscores his commitment to expanding access to advanced robotic technology. With a growing citation impact and a focus on improving oncological and functional outcomes, Dr. Vasudeo is shaping the future of robotic uro-oncology in India and beyond.

Research Focus

Key Achievements

3
H-Index
4
Papers
22
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted retroperitoneal lymph node dissection for post-chemotherapy residual mass in testicular cancer: Long-term experience from a tertiary care centre
11 citations · 2022
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 22
🏛 Institutions: Rajiv Gandhi Cancer Institute and Research Centre

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago